Edward Abell, MD
Plastic Surgery · Gainesville, GANPI 1184733370
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,862 of the $5,243 with a category attached, or 73.7%. AbbVie accounts for 60.7% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $2,352 and has fallen 72.5% since, to $646 in 2025.
Across 170 payments — averaging $30.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Integra Lifesciences Corporation$378
- Smith+Nephew$321
- Musculoskeletal Transplant Foundation Inc.$188
- Mentor Worldwide LLC$178
- Axogen$172
- plus $821 from 20 others
What the payments were for
- Travel & lodging$1,38126%
- Food & beverage$3,86274%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 87 | $3,185 |
| Integra Lifesciences Corporation | 13 | $378 |
| Smith+Nephew | 12 | $321 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $188 |
| Mentor Worldwide LLC | 12 | $178 |
| Axogen | 5 | $172 |
| Johnson & Johnson(2 entities) | 6 | $144 |
| Revance Therapeutics, Inc. | 2 | $131 |
| Davol Inc. | 4 | $88 |
| Vertex | 3 | $76 |
| Polynovo North America LLC | 2 | $53 |
| RTI Surgical, Inc | 2 | $48 |
| TELA Bio, Inc. | 2 | $44 |
| Galderma Laboratories, L.p. | 3 | $41 |
| Pacira Pharmaceuticals Incorporated | 2 | $34 |
| Lifenet Health | 1 | $26 |
| Boston Scientific | 1 | $21 |
| Next Science LLC | 1 | $17 |
| Baxter Healthcare | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Coopersurgical, Inc. | 1 | $13 |
| Medtronic | 1 | $12 |
| Aroa Biosurgery Incorporated | 2 | $11 |
| Sonex Health, Inc. | 1 | $10 |
| Reprise Biomedical, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,243 in reported general payments places this provider in the 65th percentile of 163 plastic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $310 |
| Doxycycline Hyclate | 30 | $179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $142 |
| Cefadroxil | 28 | $102 |
| Clindamycin Hcl | 14 | $62 |
| Promethazine Hcl | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Gainesville
- Puya DavoodiGainesville$28K
- Donald CampbellGainesville$5K
- David ZabelAugusta$511K
- Albert LoskenAtlanta$436K
- Jonathan NguyenAtlanta$364K
- Brian MaloneyAtlanta$224K
- Michael McNeelMarietta$160K
- Farzad NahaiAtlanta$129K
- Michael KluskaCommerce$58K
- Sara NeimanisAtlanta$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.